Central Pattana Public Company Limited (SET: CPN), Thailand’s number-one sustainable real estate developer operating under the vision ‘Imagining better futures for all’, and the developer behind Central shopping centres, office buildings, residential projects, and hotels nationwide, has reinforced the strength of Central Park Offices by welcoming GlaxoSmithKline (Thailand) Ltd. (GSK), a global biopharmaceutical and vaccine leader. The company has signed a lease agreement for Premium Grade A office space to establish its Thailand headquarters, reflecting strong confidence in the potential of Central Park Offices as a world-class office landmark designed to deliver a future-ready workplace that seamlessly integrates work, life and lifestyle.
Miss Naparat Sriwanvit, CFO and President, Hotel and Office of Central Pattana Plc., commented that, said that GSK’s decision to establish its headquarters at Central Park Offices represents another positive signal for Thailand’s healthcare industry at a time when both the public and private sectors are actively driving the country toward becoming a Health & Medical Hub of Asia. The presence of a global biopharmaceutical company choosing to locate in an international-standard office building in the city center helps strengthen Thailand’s image as a hub for the healthcare industry and further boosts confidence among international investors.
She added that the decision by a global organization such as GSK to locate at Central Park Offices reflects the readiness of Thailand’s office developments to compete on the international stage. We are not simply developing office space, but creating an ecosystem that supports business growth, drives innovation, and fosters sustainable talent development,” she said. “This also reinforces Bangkok’s role as a regional center for business and healthcare.
The development also aligns with the growing “Flight to Quality” trend among global corporations, which increasingly prioritize high-quality, international-standard office buildings capable of supporting modern workstyles and sustainability goals, including ESG commitments, rather than focusing solely on location. With this vision, Central Park Offices has emerged as a new premium office landmark, while also serving as a platform that connects leading global organizations with Thailand’s business ecosystem, further highlighting Bangkok’s potential as a metropolitan hub ready to support the growth of future industries. concluded Miss Naparat.
Ms. Marija Krstic, General Manager of GlaxoSmithKline (Thailand) Ltd., said Thailand has strong potential to become a regional health hub. Establishing our headquarters at Central Park Offices is part of our strategy to elevate our workplace in line with the era of innovation. This includes supporting hybrid working models, strengthening collaboration with partners, and creating an environment that fosters continuous healthcare innovation. She added that choosing Central Park Offices as the company’s new headquarters reflects GSK’s long-term strategy to strengthen its operations in Thailand, one of the region’s key markets. The country plays an important role in terms of healthcare system access, collaboration with government agencies, and support for medical knowledge development.
“This collaboration lays an important foundation for driving long-term partnerships and healthcare innovation, while supporting improvements in the quality of life for people in Thai society in a sustainable way”, concluded Ms. Marija.
Central Park Offices continues to develop a business ecosystem that brings together leading organizations from diverse industries within a single location to promote connectivity, collaboration, and sustainable growth. The project reinforces its role as a world-class office landmark that will help drive Bangkok toward becoming a leading regional hub for business and innovation.
